A rapid assay method for cephalosporins.

Area of Science:

• Clinical Microbiology
• Pharmaceutical Analysis
• Infectious Diseases

Background:

• Cephalosporins are vital antibiotics for treating serious infections.
• Monitoring cephalosporin levels is crucial, especially in patients with impaired renal function, to optimize efficacy and minimize nephrotoxicity.
• Existing methods for cephalosporin quantification can be time-consuming or require specialized resources.

Purpose of the Study:

• To describe a simple, rapid, and accurate assay for quantifying cephalosporins in clinical settings.
• To evaluate the assay's performance compared to standard methods.
• To assess the assay's utility in monitoring cephalosporin therapy and managing potential adverse effects.

Main Methods:

• Development of a novel assay based on the inhibition of glucose or inositol fermentation by a specific Providence bacterial strain.
• The bacterial strain used is resistant to common aminoglycoside antibiotics (gentamicin, kanamycin).
• Assay results were compared with those obtained from standard agar diffusion techniques.

Main Results:

• The described assay provides accurate results comparable to standard agar diffusion techniques.
• The assay achieves results within four hours, offering a significant time advantage.
• Concurrent administration of gentamicin or kanamycin does not interfere with the assay's results.

Conclusions:

• This rapid fermentation inhibition assay is a valuable tool for routine bacteriology departments.
• It enables effective monitoring of cephalosporin therapy in patients with severe sepsis, particularly those with renal impairment.
• The assay may contribute to understanding and preventing cephalosporin-associated nephrotoxicity.